The tea polyphenol,(−)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines
M Yokoyama, M Noguchi, Y Nakao, A Pater… - Gynecologic …, 2004 - Elsevier
Objective. To investigate the effect of the major tea polyphenol, (−)-epigallocatechin gallate (EGCG)
in cervical carcinogenesis. Methods. Cell growth rate was examined after treatment …
in cervical carcinogenesis. Methods. Cell growth rate was examined after treatment …
Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A)
…, H Nakai, T Saito, K Fujiwara, M Yokoyama… - Gynecologic …, 2015 - Elsevier
Objective In order to determine indications for less radical surgery such as modified radical
hysterectomy, the risk of pathological parametrial involvement and prognosis of FIGO stage …
hysterectomy, the risk of pathological parametrial involvement and prognosis of FIGO stage …
MR imaging in endometrial carcinoma as a diagnostic tool for the absence of myometrial invasion
Y Nakao, M Yokoyama, K Hara, Y Koyamatsu… - Gynecologic …, 2006 - Elsevier
OBJECTIVE.: To evaluate whether magnetic resonance imaging (MRI) is a reliable modality
for verifying preoperative diagnosis of stage IA endometrial carcinoma. METHODS.: One …
for verifying preoperative diagnosis of stage IA endometrial carcinoma. METHODS.: One …
Recombinant human-mouse chimeric monoclonal antibody specific for common acute lymphocytic leukemia antigen
Y Nishimura, M Yokoyama, K Araki, R Ueda, A Kudo… - Cancer research, 1987 - AACR
A human-mouse chimeric antibody constructed in the present study was specific for a human
tumor-associated antigen, common acute lymphocytic leukemia antigen. The antibody …
tumor-associated antigen, common acute lymphocytic leukemia antigen. The antibody …
A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for …
…, Y Matsumoto, H Nakai, T Inoue, M Yokoyama… - Gynecologic …, 2019 - Elsevier
… Nakai l , Takafumi Inoue m 6 , Masatoshi Yokoyama n , Takayo Kawabata o , Shoji Kodama
p 7 … Masatoshi Yokoyama and Dr. Satomi Aihara); Kumamoto University (Dr. Fumitaka Saito); …
p 7 … Masatoshi Yokoyama and Dr. Satomi Aihara); Kumamoto University (Dr. Fumitaka Saito); …
Immunopathological significance of ovarian teratoma in patients with anti-N-methyl-d-aspartate receptor encephalitis
E Tabata, M Masuda, M Eriguchi, M Yokoyama… - European …, 2014 - karger.com
Background: The clinical importance of ovarian teratoma in anti-N-methyl-D-aspartate receptor
(NMDAR) encephalitis has been established, however investigations of ovarian teratoma …
(NMDAR) encephalitis has been established, however investigations of ovarian teratoma …
A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas
Y Koyamatsu, M Yokoyama, Y Nakao, K Fukuda… - Gynecologic …, 2003 - Elsevier
OBJECTIVE: This study aimed to investigate the correlation between HPV positivity, p53
overexpression, and cell proliferative activity in cervical, vaginal, and vulvar squamous cell …
overexpression, and cell proliferative activity in cervical, vaginal, and vulvar squamous cell …
Inhibitory effect of the tea polyphenol,(−)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines
M Noguchi, M Yokoyama, S Watanabe, M Uchiyama… - Cancer letters, 2006 - Elsevier
To investigate the effect of (−)-epigallocatechin gallate (EGCG) on cervical adenocarcinoma,
we performed a cell proliferation assay. TRAP assay is used for telomerase activity, flow …
we performed a cell proliferation assay. TRAP assay is used for telomerase activity, flow …
[PDF][PDF] Analysis of pathological and clinical characteristics of cervical conization according to age group in Japan
…, M Mikami, Y Kobayashi, S Nagase, M Yokoyama… - Heliyon, 2020 - cell.com
Objective With increased screening, more patients with precancerous or early cervical cancer
are now being identified. Age at pregnancy, and thus number of patients requiring fertility …
are now being identified. Age at pregnancy, and thus number of patients requiring fertility …
Telomerase activity in gynecologic tumors
…, T Iwasaka, F Yamasaki, M Ouchida, M Yokoyama… - Gynecologic …, 1997 - Elsevier
The standard telomeric repeat assay protocol (TRAP) was used to examine telomerase
activity in 16 ovarian tumors, 16 cervical carcinomas, 4 uterine tumors, and 3 vaginal tumors. …
activity in 16 ovarian tumors, 16 cervical carcinomas, 4 uterine tumors, and 3 vaginal tumors. …